A Sequential Release Micro‐nano System for Colitis Therapy via Gut Microbiota and Immune Regulation

17-cell differentiation, respectively. In an acute colitis mouse model, this therapeutic system ameliorates colonic inflammation, enhances the abundance of gut microbiota, and modulates the mucosal immune system, showing potential in preventing colitis.